Castor Helped Power The WHO Solidarity Trial Against COVID-19

The COVID-19 pandemic stands as one of the most defining global crises in recent history, profoundly reshaping daily life and presenting unprecedented challenges for medical research. As the world raced to find effective treatments, the World Health Organization (WHO) launched the Solidarity Trial — the largest randomized clinical trial for COVID-19 — uniting the global scientific community in an urgent search for solutions.

With over 2,145 investigators working across 553 sites in 30 countries, the WHO faced immense logistical hurdles, including the need for rapid data capture, seamless scalability, and the flexibility to adapt as new information emerged. Conducting a study of this magnitude required a robust, efficient, and agile electronic data capture (EDC) system to ensure accuracy and efficiency in real-time.

This is where Castor stepped in. As the chosen EDC provider, Castor played a critical role in enabling the trial’s seamless execution. By providing a scalable, user-friendly, and compliant platform, Castor empowered researchers to collect and manage data efficiently across international borders. Its technology facilitated the rapid deployment of study protocols, ensuring that vital research progressed without delays. Download the case study below to see how Castor’s contribution accelerated the search for effective COVID-19 treatments, proving that innovative digital solutions are essential in the fight against global health crises.